Carboplatin dose calculation in lung cancer patients with low serum creatinine concentrations using CKD-EPI and Cockcroft-Gault with different weight descriptors

Lung Cancer

Volumn 79, Issue 1, 2013, Pages 54-58

  Kaag, Dieter ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Adjusted body weight; Carboplatin; CKD EPI; Cockcroft Gault; Creatinine clearance; Cytotoxic agent; Glomerular filtration rate; Predicted normal weight; Serum creatinine

Indexed keywords

CARBOPLATIN; CREATININE;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BODY MASS; BODY WEIGHT; CALCULATION; CANCER CHEMOTHERAPY; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; FEMALE; GENDER; HUMAN; KIDNEY FUNCTION; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL COMPUTING; MEDICAL RECORD REVIEW; OBESITY; PRIORITY JOURNAL; RADIATION DOSE; RETROSPECTIVE STUDY; URINALYSIS;

ADULT; AGED; AGED, 80 AND OVER; BODY WEIGHT; CARBOPLATIN; CREATININE; DRUG DOSAGE CALCULATIONS; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; OBESITY; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES;

EID: 84871062727     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2012.10.009     Document Type: Article

References (34)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90.
2. Brenner H., Francisi S., de Angelis R., Marcos-Gragera R., Verdecchia A., Gatta G., et al. Long-term survival expectations of cancer patients in Europe 2000-2002. Eur J Cancer 2009, 45:1028-1041.
3. Goldstraw P., Ball D., Jett J.R., Le Chevalier T., Lim E., Nicholson A.G., et al. Non-small-cell lung cancer. Lancet 2011, 378:1727-1740.
4. Van Meerbeeck J.P., Fennell D.A., De Ruysscher D.K.M. Small-cell lung cancer. Lancet 2011, 378:1741-1755.
5. Mathijssen R.H.J., de Jong F.A., Loos W.J., van der Bool J.M., Verweij J., Sparreboom A. Flat-fixed dosing versus body surface area-based dosing of anticancer drugs in adults: does it make a difference?. Oncologist 2007, 12:913-923.
6. Calvert A.H., Newell D.R., Gumbrell L.A., O'Reilly S., Burnell M., Boxall F.E., et al. Carboplatin dosage, prospective evaluation of a simple formula based on renal function. J Clin Oncol 1989, 7:1748-1756.
7. Calvert A.H., Egorin M.J. Carboplatin dosing formulae: gender bias and the use of creatinine-based methodologies. Eur J Cancer 2002, 38:11-16.
8. Alberts D.S., Dorr R.T. New perspectives on an old friend: optimizing carboplatin for the treatment of solid tumors. Oncologist 1998, 3:15-34.
9. Cockcroft D.W., Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 1976, 16:31-41.
10. 99mDTPA clearance) in cancer patients. Ann Oncol 2002, 13:949-955.
11. Dooley M.J., Poole S.G., Rischin D., Webster L.K. Carboplatin dosing: gender bias and inaccurate estimates of glomerular filtration rates. Eur J Cancer 2002, 38:44-51.
12. Coresh J., Astor B.C., McQuillan G., Kusek J., Greene T., Van Lente F., et al. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis 2002, 39:920-929.
13. Léger F., Séronie-Vivien S., Makdessi J., Lochon I., Delord J.P., Sarda C., et al. Impact of the biochemical assay for serum creatinine measurement on the individual carboplatin dosing: a prospective study. Eur J Cancer 2002, 38:52-56.
14. Levey A.S., Coresh J., Greene T., Marsh J., Stevens L.A., Kusek J.W., et al. Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem 2007, 53:766-772.
15. Murray B., Bates J., Buie L. Impact of a new assay for measuring serum creatinine levels on carboplatin dosing. Am J Health-Syst Pharm 2012, 69:1136-1141.
16. Green B., Duffull S.B. What is the best size descriptor to use for pharmacokinetic studies in the obese?. Br J Clin Pharmacol 2004, 58:119-133.
17. Duffull S.B., Dooley M.J., Green B., Poole S.G., Kirkpatrick C.M.J. A standard weight descriptor for dose adjustment in the obese patient. Clin Pharmacokinet 2004, 43:1167-1178.
18. Ekhart C., Rodenhuis S., Schellens J.H.M., Beijnen J.H., Huitema A.D.R. Carboplatin dosing in overweight and obese patients with normal renal function, does weight matter?. Cancer Chemother Pharmacol 2009, 64:115-122.
19. Herrington J.D., Tran H.T., Riggs M.W. Prospective evaluation of carboplatin AUC dosing in patients with a BMI≥27 or cachexia. Cancer Chemother Pharmacol 2006, 57:241-247.
20. Sparreboom A., Wolff A.C., Mathijssen R.H.J., Chatelut E., Rowinsky E.K., Verweij J., et al. Evaluation of alternate size descriptors for dose calculation of anticancer drugs in the obese. J Clin Oncol 2007, 25:4707-4713.
21. Kaag D. Retrospective evaluation of various weight descriptors and formulae for dose calculation of carboplatin in obese patients. Krankenhauspharmazie 2012, 33:2-10. [in German].
22. Boumedien F., Arsenault Y., LeTarte N. Impact of weight and creatinine measurements in carboplatin dosing. J Clin Oncol 2012, 30(Suppl.):e13027. [abstract e13027].
23. Levey A.S., Stevens L.A., Schmid C.H., Zhang Y.L., Castro A.F., Feldman H.I., et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009, 150:604-612.
24. Redal-Baigorri B., Stokholm K.H., Rasmussen K., Jeppesen N. Estimation of kidney function in cancer patients. Dan Med Bull 2011, 58:A4236.
25. Trobec K., Knez L., Brguljan P.M., Cufer T., Lainscak M. Estimation of renal function in lung cancer patients. Lung Cancer 2012, 76:397-402.
26. Dooley M.J., Singh S., Rischin D. Rounding of low serum creatinine levels and consequent impact on accuracy of bedside estimates of renal function in cancer patients. Br J Cancer 2004, 90:991-995.
27. Kaag D., Steins M. Impact of rounding low serum creatinine concentrations on the accuracy of carboplatin AUC dosing. Eur J Hosp Pharm Sci 2011, 17:13-17.
28. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999, 130:461-470.
29. Schaeffner E.S., Ebert N., Delanaye P., Frei U., Gaedeke J., Jakob O., et al. Two novel equations to estimate kidney function in persons aged 70 years or older. Ann Intern Med 2012, 157:471-481.
30. Schmitt A., Gladieff L., Lansiaux A., Bobin-Dubigeon C., Etienne-Grimaldi M.C., Boisdron-Celle M., et al. A universal formula based on cystatin C to perform individual dosing of carboplatin in normal weight, underweight, and obese patients. Clin Cancer Res 2009, 15:3633-3639.
31. Inker L.A., Schmid C.H., Tighiouart H., Eckfeldt J.H., Feldman H.I., Greene T., et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 2012, 367:20-29.
32. BMI classification. [accessed 07.09.12]. http://www.who.int/bmi/index.jsp%3FintroPage=intro_3.html.
33. Stevens L.A., Coresh J., Greene T., Levey A.S. Assessing kidney function - measured and estimated glomerular filtration rate. N Engl J Med 2006, 354:2473-2483.
34. Traynor J., Mactier R., Geddes C.C., Fox J.G. How to measure renal function in clinical practice. BMJ 2006, 333:733-737.